<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2004-04-13" modified="2024-10-02" version="192" xmlns="http://uniprot.org/uniprot">
  <accession>Q86U42</accession>
  <accession>D3DS49</accession>
  <accession>O43484</accession>
  <name>PABP2_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="22">Polyadenylate-binding protein 2</fullName>
      <shortName>PABP-2</shortName>
      <shortName>Poly(A)-binding protein 2</shortName>
    </recommendedName>
    <alternativeName>
      <fullName>Nuclear poly(A)-binding protein 1</fullName>
    </alternativeName>
    <alternativeName>
      <fullName>Poly(A)-binding protein II</fullName>
      <shortName>PABII</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Polyadenylate-binding nuclear protein 1</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name evidence="23" type="primary">PABPN1</name>
    <name type="synonym">PAB2</name>
    <name type="synonym">PABP2</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1998" name="Nat. Genet." volume="18" first="164" last="167">
      <title>Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.</title>
      <authorList>
        <person name="Brais B."/>
        <person name="Bouchard J.-P."/>
        <person name="Xie Y.-G."/>
        <person name="Rochefort D.L."/>
        <person name="Chretien N."/>
        <person name="Tome F.M.S."/>
        <person name="Lafreniere R.G."/>
        <person name="Rommens J.M."/>
        <person name="Uyama E."/>
        <person name="Nohira O."/>
        <person name="Blumen S."/>
        <person name="Korcyn A.D."/>
        <person name="Heutink P."/>
        <person name="Mathieu J."/>
        <person name="Duranceau A."/>
        <person name="Codere F."/>
        <person name="Fardeau M."/>
        <person name="Rouleau G.A."/>
      </authorList>
      <dbReference type="PubMed" id="9462747"/>
      <dbReference type="DOI" id="10.1038/ng0298-164"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
    <scope>POLYMORPHISM OF POLY-ALA REGION</scope>
    <scope>DISEASE</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="404" last="404">
      <authorList>
        <person name="Brais B."/>
        <person name="Bouchard J.-P."/>
        <person name="Xie Y.-G."/>
        <person name="Rochefort D.L."/>
        <person name="Chretien N."/>
        <person name="Tome F.M.S."/>
        <person name="Lafreniere R.G."/>
        <person name="Rommens J.M."/>
        <person name="Uyama E."/>
        <person name="Nohira O."/>
        <person name="Blumen S."/>
        <person name="Korcyn A.D."/>
        <person name="Heutink P."/>
        <person name="Mathieu J."/>
        <person name="Duranceau A."/>
        <person name="Codere F."/>
        <person name="Fardeau M."/>
        <person name="Rouleau G.A."/>
      </authorList>
    </citation>
    <scope>ERRATUM OF PUBMED:9462747</scope>
  </reference>
  <reference key="3">
    <citation type="submission" date="2003-02" db="EMBL/GenBank/DDBJ databases">
      <title>Full-length cDNA libraries and normalization.</title>
      <authorList>
        <person name="Li W.B."/>
        <person name="Gruber C."/>
        <person name="Jessee J."/>
        <person name="Polayes D."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
    <source>
      <tissue>Fetal brain</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Skin</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="journal article" date="1999" name="EMBO J." volume="18" first="2273" last="2283">
      <title>Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.</title>
      <authorList>
        <person name="Chen Z."/>
        <person name="Li Y."/>
        <person name="Krug R.M."/>
      </authorList>
      <dbReference type="PubMed" id="10205180"/>
      <dbReference type="DOI" id="10.1093/emboj/18.8.2273"/>
    </citation>
    <scope>PARTIAL NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>ASSOCIATION WITH CPSF AND NS/NS1</scope>
    <scope>INTERACTION WITH NS/NS1</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="submission" date="2005-04" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 2-17 AND 228-238</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
    <scope>ACETYLATION AT ALA-2</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>B-cell lymphoma</tissue>
    </source>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="2321" last="2328">
      <title>Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA.</title>
      <authorList>
        <person name="Calado A."/>
        <person name="Tome F.M.S."/>
        <person name="Brais B."/>
        <person name="Rouleau G.A."/>
        <person name="Kuehn U."/>
        <person name="Wahle E."/>
        <person name="Carmo-Fonseca M."/>
      </authorList>
      <dbReference type="PubMed" id="11001936"/>
      <dbReference type="DOI" id="10.1093/oxfordjournals.hmg.a018924"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2000" name="RNA" volume="6" first="245" last="256">
      <title>Deciphering the cellular pathway for transport of poly(A)-binding protein II.</title>
      <authorList>
        <person name="Calado A."/>
        <person name="Kutay U."/>
        <person name="Kuehn U."/>
        <person name="Wahle E."/>
        <person name="Carmo-Fonseca M."/>
      </authorList>
      <dbReference type="PubMed" id="10688363"/>
      <dbReference type="DOI" id="10.1017/s1355838200991908"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>NUCLEOCYTOPLASMIC SHUTTLING</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="2341" last="2351">
      <title>Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.</title>
      <authorList>
        <person name="Fan X."/>
        <person name="Dion P."/>
        <person name="Laganiere J."/>
        <person name="Brais B."/>
        <person name="Rouleau G.A."/>
      </authorList>
      <dbReference type="PubMed" id="11689481"/>
      <dbReference type="DOI" id="10.1093/hmg/10.21.2341"/>
    </citation>
    <scope>FUNCTION IN CELL DEATH</scope>
    <scope>HOMOOLIGOMERIZATION</scope>
    <scope>MUTAGENESIS OF 213-LYS--PHE-220 AND 301-SER--TYR-306</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="1129" last="1139">
      <title>The product of an oculopharyngeal muscular dystrophy gene, poly(A)-binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression.</title>
      <authorList>
        <person name="Kim Y.-J."/>
        <person name="Noguchi S."/>
        <person name="Hayashi Y.K."/>
        <person name="Tsukahara T."/>
        <person name="Shimizu T."/>
        <person name="Arahata K."/>
      </authorList>
      <dbReference type="PubMed" id="11371506"/>
      <dbReference type="DOI" id="10.1093/hmg/10.11.1129"/>
    </citation>
    <scope>FUNCTION IN MYOGENIC DIFFERENTIATION</scope>
    <scope>ASSOCIATION WITH SKIP AND MYOD1</scope>
    <scope>INTERACTION WITH SKIP</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2003" name="NeuroReport" volume="14" first="2331" last="2335">
      <title>An aggregate-prone conformational epitope in trinucleotide repeat diseases.</title>
      <authorList>
        <person name="Sugaya K."/>
        <person name="Matsubara S."/>
        <person name="Miyamoto K."/>
        <person name="Kawata A."/>
        <person name="Hayashi H."/>
      </authorList>
      <dbReference type="PubMed" id="14663186"/>
      <dbReference type="DOI" id="10.1097/00001756-200312190-00009"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="35788" last="35797">
      <title>Distinct sequence motifs within the 68-kDa subunit of cleavage factor Im mediate RNA binding, protein-protein interactions, and subcellular localization.</title>
      <authorList>
        <person name="Dettwiler S."/>
        <person name="Aringhieri C."/>
        <person name="Cardinale S."/>
        <person name="Keller W."/>
        <person name="Barabino S.M."/>
      </authorList>
      <dbReference type="PubMed" id="15169763"/>
      <dbReference type="DOI" id="10.1074/jbc.m403927200"/>
    </citation>
    <scope>INTERACTION WITH NUDT21/CPSF5</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
      <title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
        <person name="Gnad F."/>
        <person name="Macek B."/>
        <person name="Kumar C."/>
        <person name="Mortensen P."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="17081983"/>
      <dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2007" name="Chromosoma" volume="116" first="53" last="64">
      <title>FRG1P-mediated aggregation of proteins involved in pre-mRNA processing.</title>
      <authorList>
        <person name="van Koningsbruggen S."/>
        <person name="Straasheijm K.R."/>
        <person name="Sterrenburg E."/>
        <person name="de Graaf N."/>
        <person name="Dauwerse H.G."/>
        <person name="Frants R.R."/>
        <person name="van der Maarel S.M."/>
      </authorList>
      <dbReference type="PubMed" id="17103222"/>
      <dbReference type="DOI" id="10.1007/s00412-006-0083-3"/>
    </citation>
    <scope>INTERACTION WITH FRG1</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="798" last="811">
      <title>Molecular composition of IMP1 ribonucleoprotein granules.</title>
      <authorList>
        <person name="Joeson L."/>
        <person name="Vikesaa J."/>
        <person name="Krogh A."/>
        <person name="Nielsen L.K."/>
        <person name="Hansen T."/>
        <person name="Borup R."/>
        <person name="Johnsen A.H."/>
        <person name="Christiansen J."/>
        <person name="Nielsen F.C."/>
      </authorList>
      <dbReference type="PubMed" id="17289661"/>
      <dbReference type="DOI" id="10.1074/mcp.m600346-mcp200"/>
    </citation>
    <scope>IDENTIFICATION IN A MRNP GRANULE COMPLEX</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-95 AND SER-150</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-95 AND SER-150</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="794" last="805">
      <title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.</title>
      <authorList>
        <person name="Skourti-Stathaki K."/>
        <person name="Proudfoot N.J."/>
        <person name="Gromak N."/>
      </authorList>
      <dbReference type="PubMed" id="21700224"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2011.04.026"/>
    </citation>
    <scope>INTERACTION WITH SETX</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-95</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
      <title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Sumpton D."/>
        <person name="Martinez A."/>
        <person name="Lilla S."/>
        <person name="Espagne C."/>
        <person name="Meinnel T."/>
        <person name="Giglione C."/>
      </authorList>
      <dbReference type="PubMed" id="22223895"/>
      <dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
    <scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-150</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-235</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
      <title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
      <authorList>
        <person name="Guo A."/>
        <person name="Gu H."/>
        <person name="Zhou J."/>
        <person name="Mulhern D."/>
        <person name="Wang Y."/>
        <person name="Lee K.A."/>
        <person name="Yang V."/>
        <person name="Aguiar M."/>
        <person name="Kornhauser J."/>
        <person name="Jia X."/>
        <person name="Ren J."/>
        <person name="Beausoleil S.A."/>
        <person name="Silva J.C."/>
        <person name="Vemulapalli V."/>
        <person name="Bedford M.T."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="24129315"/>
      <dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
    </citation>
    <scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-259 AND ARG-263</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2016" name="Mol. Cell" volume="64" first="520" last="533">
      <title>Identification of a nuclear exosome decay pathway for processed transcripts.</title>
      <authorList>
        <person name="Meola N."/>
        <person name="Domanski M."/>
        <person name="Karadoulama E."/>
        <person name="Chen Y."/>
        <person name="Gentil C."/>
        <person name="Pultz D."/>
        <person name="Vitting-Seerup K."/>
        <person name="Lykke-Andersen S."/>
        <person name="Andersen J.S."/>
        <person name="Sandelin A."/>
        <person name="Jensen T.H."/>
      </authorList>
      <dbReference type="PubMed" id="27871484"/>
      <dbReference type="DOI" id="10.1016/j.molcel.2016.09.025"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBUNIT</scope>
    <scope>INTERACTION WITH ZFC3H1</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2016" name="Neuromuscul. Disord." volume="26" first="436" last="440">
      <title>Nuclear inclusions mimicking poly(A)-binding protein nuclear 1 inclusions in a case of inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia with a novel mutation in the valosin-containing protein gene.</title>
      <authorList>
        <person name="Matsubara S."/>
        <person name="Shimizu T."/>
        <person name="Komori T."/>
        <person name="Mori-Yoshimura M."/>
        <person name="Minami N."/>
        <person name="Hayashi Y.K."/>
      </authorList>
      <dbReference type="PubMed" id="27209344"/>
      <dbReference type="DOI" id="10.1016/j.nmd.2016.05.001"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="553" last="553">
      <title>Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.</title>
      <authorList>
        <person name="van der Sluijs B.M."/>
        <person name="van Engelen B.G.M."/>
        <person name="Hoefsloot L.H."/>
      </authorList>
      <dbReference type="PubMed" id="12673802"/>
      <dbReference type="DOI" id="10.1002/humu.9138"/>
    </citation>
    <scope>VARIANT OPMD1 ALA-6 INS</scope>
    <scope>INVOLVEMENT IN OPMD1</scope>
  </reference>
  <comment type="function">
    <text evidence="2 10 19">Involved in the 3'-end formation of mRNA precursors (pre-mRNA) by the addition of a poly(A) tail of 200-250 nt to the upstream cleavage product (By similarity). Stimulates poly(A) polymerase (PAPOLA) conferring processivity on the poly(A) tail elongation reaction and controls also the poly(A) tail length (By similarity). Increases the affinity of poly(A) polymerase for RNA (By similarity). Is also present at various stages of mRNA metabolism including nucleocytoplasmic trafficking and nonsense-mediated decay (NMD) of mRNA. Cooperates with SKIP to synergistically activate E-box-mediated transcription through MYOD1 and may regulate the expression of muscle-specific genes (PubMed:11371506). Binds to poly(A) and to poly(G) with high affinity (By similarity). May protect the poly(A) tail from degradation (By similarity). Subunit of the trimeric poly(A) tail exosome targeting (PAXT) complex, a complex that directs a subset of long and polyadenylated poly(A) RNAs for exosomal degradation. The RNA exosome is fundamental for the degradation of RNA in eukaryotic nuclei. Substrate targeting is facilitated by its cofactor MTREX, which links to RNA-binding protein adapters (PubMed:27871484).</text>
  </comment>
  <comment type="subunit">
    <text evidence="3 7 10 14 15 16 17 19">May interact with SETX (PubMed:21700224). Monomer and homooligomer. Binds RNA as a monomer and oligomerizes when bound to poly(A). Interacts with PAPOLA, but only in presence of oligo(A) RNA. Interacts with transportin. Identified in a IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs. Association in a ternary complex with CPSF4 and influenza A virus NS1 blocks pre-mRNAs processing, thereby preventing nuclear export of host cell mRNAs. Associates in a single complex with SKIP and MYOD1 and interacts with SKIP in differentiated myocytes. Interacts with NUDT21/CPSF5. Interacts (via RRM domain and C-terminal arginine-rich region) with ZFP36 (via hypophosphorylated form); this interaction occurs in the nucleus in a RNA-independent manner, decreases in presence of single-stranded poly(A) RNA-oligomer and in a p38-dependent-manner and may down-regulated RNA poly(A) polymerase activity (By similarity). Component of the poly(A) tail exosome targeting (PAXT) complex made of accessory factors, such as PABPN1, ZFC3H1 and MTREX (PubMed:27871484). Interacts with ZFC3H1 in a RNase-insensitive manner (PubMed:27871484). Interacts with FRG1 (PubMed:17103222).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1226435">
      <id>Q86U42</id>
    </interactant>
    <interactant intactId="EBI-81531">
      <id>P11940</id>
      <label>PABPC1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-1226435">
      <id>Q86U42</id>
    </interactant>
    <interactant intactId="EBI-632715">
      <id>Q13573</id>
      <label>SNW1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location evidence="8 9 13 18">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="8 9 13 16">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="8 10">Nucleus speckle</location>
    </subcellularLocation>
    <text evidence="2 8 9 10 13 16 18">Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Shuttles between the nucleus and the cytoplasm but predominantly found in the nucleus (PubMed:10688363). Its nuclear import may involve the nucleocytoplasmic transport receptor transportin and a RAN-GTP-sensitive import mechanism (By similarity). Is exported to the cytoplasm by a carrier-mediated pathway that is independent of mRNA traffic. Colocalizes with SKIP and poly(A) RNA in nuclear speckles (By similarity). Intranuclear filamentous inclusions or 'aggregates' are detected in the myocytes of patients; these inclusions contain PABPN1, ubiquitin, subunits of the proteasome and poly(A) RNA.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>Q86U42-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>Q86U42-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_009847 VSP_009848"/>
    </isoform>
    <isoform>
      <id>Q92843-2</id>
      <name>3</name>
      <name>BCL2L2-PABPN1</name>
      <sequence type="external"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text>Ubiquitous.</text>
  </comment>
  <comment type="domain">
    <text evidence="1">The RRM domain is essential for specific adenine bases recognition in the poly(A) tail but not sufficient for poly(A) binding.</text>
  </comment>
  <comment type="PTM">
    <text evidence="1">Arginine dimethylation is asymmetric and involves PRMT1 and PRMT3. It does not influence the RNA binding properties (By similarity).</text>
  </comment>
  <comment type="polymorphism">
    <text>The poly-Ala region of PABPN1 is polymorphic (6-7 repeats) in the population and is expanded to 8-13 repeats in OPMD1 patients. Compound heterozygotes for (GCG)9 mutation and a (GCG)7 allele result in earlier onset and more severe clinical manifestations of the disease.</text>
  </comment>
  <comment type="disease" evidence="12">
    <disease id="DI-00881">
      <name>Oculopharyngeal muscular dystrophy 1</name>
      <acronym>OPMD1</acronym>
      <description>An autosomal dominant, late-onset, slowly progressive myopathy characterized by eyelid ptosis, dysphagia and, sometimes by other cranial and limb-muscle involvement.</description>
      <dbReference type="MIM" id="164300"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="miscellaneous">
    <text evidence="11">The association of the expanded polyalanine mutations together with the capability to oligomerize may induce intranuclear inclusions and cell death. Expanded polyalanine mutations may either result from unequal crossing over during germ cell homologous recombination or from DNA slippage. The pathogenic mechanisms mediated by polyalanine expansion mutations may be either a general disruption of cellular RNA metabolism due to the trapping by the inclusions of PABPN1, mRNAs and/or nuclear proteins, resulting in the induction of cell death; or may change the normal muscle cell differentiation.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 2</molecule>
    <text evidence="22">May be due to a competing donor splice site.</text>
  </comment>
  <comment type="sequence caution" evidence="22">
    <conflict type="erroneous initiation">
      <sequence resource="EMBL-CDS" id="CAD62310" version="1"/>
    </conflict>
    <text>Extended N-terminus.</text>
  </comment>
  <dbReference type="EMBL" id="AF026029">
    <property type="protein sequence ID" value="AAC39596.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX247976">
    <property type="protein sequence ID" value="CAD62310.1"/>
    <property type="status" value="ALT_INIT"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471078">
    <property type="protein sequence ID" value="EAW66167.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471078">
    <property type="protein sequence ID" value="EAW66168.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC010939">
    <property type="protein sequence ID" value="AAH10939.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS86374.1">
    <molecule id="Q86U42-2"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS9592.1">
    <molecule id="Q86U42-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_004634.1">
    <molecule id="Q86U42-1"/>
    <property type="nucleotide sequence ID" value="NM_004643.3"/>
  </dbReference>
  <dbReference type="PDB" id="3B4D">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=167-254"/>
  </dbReference>
  <dbReference type="PDB" id="3B4M">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.82 A"/>
    <property type="chains" value="A/B/C/D=167-254"/>
  </dbReference>
  <dbReference type="PDB" id="3UCG">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.95 A"/>
    <property type="chains" value="A=167-254"/>
  </dbReference>
  <dbReference type="PDBsum" id="3B4D"/>
  <dbReference type="PDBsum" id="3B4M"/>
  <dbReference type="PDBsum" id="3UCG"/>
  <dbReference type="AlphaFoldDB" id="Q86U42"/>
  <dbReference type="SMR" id="Q86U42"/>
  <dbReference type="BioGRID" id="113777">
    <property type="interactions" value="201"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-2750">
    <property type="entry name" value="Poly(A) tail exosome targeting complex, RBM26 variant"/>
  </dbReference>
  <dbReference type="ComplexPortal" id="CPX-2752">
    <property type="entry name" value="Poly(A) tail exosome targeting complex, RBM27 variant"/>
  </dbReference>
  <dbReference type="DIP" id="DIP-37968N"/>
  <dbReference type="IntAct" id="Q86U42">
    <property type="interactions" value="87"/>
  </dbReference>
  <dbReference type="MINT" id="Q86U42"/>
  <dbReference type="STRING" id="9606.ENSP00000216727"/>
  <dbReference type="GlyGen" id="Q86U42">
    <property type="glycosylation" value="7 sites, 1 O-linked glycan (7 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q86U42"/>
  <dbReference type="PhosphoSitePlus" id="Q86U42"/>
  <dbReference type="SwissPalm" id="Q86U42"/>
  <dbReference type="BioMuta" id="PABPN1"/>
  <dbReference type="DMDM" id="46403176"/>
  <dbReference type="jPOST" id="Q86U42"/>
  <dbReference type="MassIVE" id="Q86U42"/>
  <dbReference type="PaxDb" id="9606-ENSP00000216727"/>
  <dbReference type="PeptideAtlas" id="Q86U42"/>
  <dbReference type="ProteomicsDB" id="69766">
    <molecule id="Q86U42-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="69767">
    <molecule id="Q86U42-2"/>
  </dbReference>
  <dbReference type="Pumba" id="Q86U42"/>
  <dbReference type="TopDownProteomics" id="Q86U42-1">
    <molecule id="Q86U42-1"/>
  </dbReference>
  <dbReference type="Antibodypedia" id="43">
    <property type="antibodies" value="223 antibodies from 31 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="8106"/>
  <dbReference type="Ensembl" id="ENST00000216727.9">
    <molecule id="Q86U42-1"/>
    <property type="protein sequence ID" value="ENSP00000216727.4"/>
    <property type="gene ID" value="ENSG00000100836.11"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000397276.6">
    <molecule id="Q86U42-2"/>
    <property type="protein sequence ID" value="ENSP00000380446.2"/>
    <property type="gene ID" value="ENSG00000100836.11"/>
  </dbReference>
  <dbReference type="GeneID" id="8106"/>
  <dbReference type="KEGG" id="hsa:8106"/>
  <dbReference type="MANE-Select" id="ENST00000216727.9">
    <property type="protein sequence ID" value="ENSP00000216727.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_004643.4"/>
    <property type="RefSeq protein sequence ID" value="NP_004634.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001wjj.4">
    <molecule id="Q86U42-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:8565"/>
  <dbReference type="CTD" id="8106"/>
  <dbReference type="DisGeNET" id="8106"/>
  <dbReference type="GeneCards" id="PABPN1"/>
  <dbReference type="GeneReviews" id="PABPN1"/>
  <dbReference type="HGNC" id="HGNC:8565">
    <property type="gene designation" value="PABPN1"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000100836">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="PABPN1"/>
  <dbReference type="MIM" id="164300">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="602279">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q86U42"/>
  <dbReference type="OpenTargets" id="ENSG00000100836"/>
  <dbReference type="Orphanet" id="270">
    <property type="disease" value="Oculopharyngeal muscular dystrophy"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA32891"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000100836"/>
  <dbReference type="eggNOG" id="KOG4209">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000154606"/>
  <dbReference type="HOGENOM" id="CLU_012062_23_1_1"/>
  <dbReference type="InParanoid" id="Q86U42"/>
  <dbReference type="OMA" id="ARFTCHE"/>
  <dbReference type="OrthoDB" id="155884at2759"/>
  <dbReference type="PhylomeDB" id="Q86U42"/>
  <dbReference type="TreeFam" id="TF105907"/>
  <dbReference type="PathwayCommons" id="Q86U42"/>
  <dbReference type="Reactome" id="R-HSA-168315">
    <property type="pathway name" value="Inhibition of Host mRNA Processing and RNA Silencing"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-72187">
    <property type="pathway name" value="mRNA 3'-end processing"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-72203">
    <property type="pathway name" value="Processing of Capped Intron-Containing Pre-mRNA"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-73856">
    <property type="pathway name" value="RNA Polymerase II Transcription Termination"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-77595">
    <property type="pathway name" value="Processing of Intronless Pre-mRNAs"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9820865">
    <property type="pathway name" value="Z-decay: degradation of maternal mRNAs by zygotically expressed factors"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q86U42"/>
  <dbReference type="SIGNOR" id="Q86U42"/>
  <dbReference type="BioGRID-ORCS" id="8106">
    <property type="hits" value="758 hits in 1106 CRISPR screens"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q86U42"/>
  <dbReference type="GeneWiki" id="PABPN1"/>
  <dbReference type="GenomeRNAi" id="8106"/>
  <dbReference type="Pharos" id="Q86U42">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 14"/>
  </dbReference>
  <dbReference type="RNAct" id="Q86U42">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000100836">
    <property type="expression patterns" value="Expressed in right testis and 173 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q86U42">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042405">
    <property type="term" value="C:nuclear inclusion body"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016607">
    <property type="term" value="C:nuclear speck"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-SubCell"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1990904">
    <property type="term" value="C:ribonucleoprotein complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008143">
    <property type="term" value="F:poly(A) binding"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070063">
    <property type="term" value="F:RNA polymerase binding"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071222">
    <property type="term" value="P:cellular response to lipopolysaccharide"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000165">
    <property type="term" value="P:MAPK cascade"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006397">
    <property type="term" value="P:mRNA processing"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006936">
    <property type="term" value="P:muscle contraction"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016973">
    <property type="term" value="P:poly(A)+ mRNA export from nucleus"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:1904247">
    <property type="term" value="P:positive regulation of polynucleotide adenylyltransferase activity"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006396">
    <property type="term" value="P:RNA processing"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="CDD" id="cd12550">
    <property type="entry name" value="RRM_II_PABPN1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.70.330">
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR012677">
    <property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035979">
    <property type="entry name" value="RBD_domain_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000504">
    <property type="entry name" value="RRM_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR23236">
    <property type="entry name" value="EUKARYOTIC TRANSLATION INITIATION FACTOR 4B/4H"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR23236:SF16">
    <property type="entry name" value="POLYADENYLATE-BINDING PROTEIN 2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00076">
    <property type="entry name" value="RRM_1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00360">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54928">
    <property type="entry name" value="RNA-binding domain, RBD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50102">
    <property type="entry name" value="RRM"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0175">Coiled coil</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0507">mRNA processing</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0818">Triplet repeat expansion</keyword>
  <feature type="initiator methionine" description="Removed" evidence="20 25 27 28 29 30">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000081711" description="Polyadenylate-binding protein 2">
    <location>
      <begin position="2"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="domain" description="RRM" evidence="5">
    <location>
      <begin position="172"/>
      <end position="249"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="6">
    <location>
      <begin position="1"/>
      <end position="115"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with SKIP" evidence="10">
    <location>
      <begin position="2"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="region of interest" description="Stimulates PAPOLA" evidence="1">
    <location>
      <begin position="119"/>
      <end position="147"/>
    </location>
  </feature>
  <feature type="region of interest" description="Necessary for homooligomerization">
    <location>
      <begin position="155"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with PAPOLA" evidence="1">
    <location>
      <begin position="286"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="coiled-coil region" evidence="4">
    <location>
      <begin position="115"/>
      <end position="151"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="6">
    <location>
      <begin position="51"/>
      <end position="70"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Acidic residues" evidence="6">
    <location>
      <begin position="99"/>
      <end position="115"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylalanine" evidence="20 25 27 28 29 30">
    <location>
      <position position="2"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine" evidence="3">
    <location>
      <position position="17"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="27 28 31">
    <location>
      <position position="19"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="24">
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="24 27 28">
    <location>
      <position position="95"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="24 26 27 31">
    <location>
      <position position="150"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="33">
    <location>
      <position position="235"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="2">
    <location>
      <position position="238"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="2">
    <location>
      <position position="238"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="2">
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="32">
    <location>
      <position position="259"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="2">
    <location>
      <position position="263"/>
    </location>
  </feature>
  <feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="32">
    <location>
      <position position="263"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="265"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="267"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="269"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="277"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="279"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="287"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="289"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="291"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="294"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="296"/>
    </location>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="2">
    <location>
      <position position="298"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009847" description="In isoform 2." evidence="21">
    <original>GR</original>
    <variation>SG</variation>
    <location>
      <begin position="295"/>
      <end position="296"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_009848" description="In isoform 2." evidence="21">
    <location>
      <begin position="297"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_018179">
    <original>A</original>
    <variation>AAAA</variation>
    <location>
      <position position="6"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes self-association, protein aggregation and cell death." evidence="11">
    <location>
      <begin position="213"/>
      <end position="220"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes self-association, protein aggregation and cell death." evidence="11">
    <location>
      <begin position="301"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="167"/>
      <end position="171"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="173"/>
      <end position="178"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="185"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="193"/>
      <end position="195"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="198"/>
      <end position="206"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="208"/>
      <end position="211"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="214"/>
      <end position="222"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="224"/>
      <end position="229"/>
    </location>
  </feature>
  <feature type="helix" evidence="34">
    <location>
      <begin position="230"/>
      <end position="232"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="243"/>
      <end position="246"/>
    </location>
  </feature>
  <feature type="turn" evidence="34">
    <location>
      <begin position="247"/>
      <end position="250"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1"/>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="Q28165"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="3">
    <source>
      <dbReference type="UniProtKB" id="Q8CCS6"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4"/>
  <evidence type="ECO:0000255" key="5">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00176"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="6">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="10205180"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="10688363"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="11001936"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="11371506"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="11689481"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="12673802"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="14663186"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="15169763"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="17103222"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="17289661"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="21700224"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="27209344"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="27871484"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source ref="7"/>
  </evidence>
  <evidence type="ECO:0000303" key="21">
    <source ref="3"/>
  </evidence>
  <evidence type="ECO:0000305" key="22"/>
  <evidence type="ECO:0000312" key="23">
    <source>
      <dbReference type="HGNC" id="HGNC:8565"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="24">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="25">
    <source>
      <dbReference type="PubMed" id="19413330"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="26">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="27">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="28">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="29">
    <source>
      <dbReference type="PubMed" id="22223895"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="30">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="32">
    <source>
      <dbReference type="PubMed" id="24129315"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="33">
    <source>
      <dbReference type="PubMed" id="24275569"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="34">
    <source>
      <dbReference type="PDB" id="3UCG"/>
    </source>
  </evidence>
  <sequence length="306" mass="32749" checksum="2E5B0AEFEA5AFBC3" modified="2007-01-23" version="3">MAAAAAAAAAAGAAGGRGSGPGRRRHLVPGAGGEAGEGAPGGAGDYGNGLESEELEPEELLLEPEPEPEPEEEPPRPRAPPGAPGPGPGSGAPGSQEEEEEPGLVEGDPGDGAIEDPELEAIKARVREMEEEAEKLKELQNEVEKQMNMSPPPGNAGPVIMSIEEKMEADARSIYVGNVDYGATAEELEAHFHGCGSVNRVTILCDKFSGHPKGFAYIEFSDKESVRTSLALDESLFRGRQIKVIPKRTNRPGISTTDRGFPRARYRARTTNYNSSRSRFYSGFNSRPRGRVYRGRARATSWYSPY</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>